Search
Arbutus Biopharma Corp
ABUSAdd to Watchlist
4.340USD
-0.070-1.59%
Close 07-31 16:00（ET）Quotes delayed by 15 min
857.31MMarket Cap
5.23P/E TTM
ABUS Financials
See Arbutus Biopharma Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Arbutus Biopharma Corp Earnings Date
Latest Release
May 13, 2026
EPS / Forecast
0.88/-0.03
Revenue / Forecast
179.13M/750.00K
Period
FY2025 Earnings
Revenue(YoY)
14.08M
128.21%
EPS(YoY)
-0.17
53.58%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total revenue reached 14.08M, with a year-on-year change of 6.17M.
What are the current assets of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its current assets were 94.46M, with a year-on-year change of -25.81.
What are the total assets of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total assets of Arbutus Biopharma Corp were 94.62M, with a year-on-year change of -28.16.
What are the total liabilities of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total liabilities of Arbutus Biopharma Corp were 18.04M, with a year-on-year change of -47.46.
What is the total equity of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total equity of Arbutus Biopharma Corp was 76.58M, with a year-on-year change of -21.35.
What is the net operating income of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net operating income of Arbutus Biopharma Corp was -27.05M, with a year-on-year change of 61.34.
What is the net investment of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net investment of Arbutus Biopharma Corp was 15.58M, with a year-on-year change of -32.11.
What is the net financing of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net financing of Arbutus Biopharma Corp was 5.72M, with a year-on-year change of -89.00.
What is the Earnings Per Share (EPS) of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.17, with a year-on-year change of 53.58.
What is the net income of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net income was -33.50M, with a year-on-year change of 52.09.
What is the net margin of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net profit margin was -237.88, with a year-on-year change of 79.00.
What is the debt-to-asset ratio of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its debt-to-asset ratio was 3.64, with a year-on-year change of -0.78.
What is the Return on Equity (ROE) of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its Return on Equity (ROE) was -38.52, with a year-on-year change of 43.98.
What is the Return on Assets (ROA) of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its Return on Assets (ROA) was -29.60, with a year-on-year change of 41.55.
What is the operating profit of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its operating profit was -27.05M, with a year-on-year change of 61.34.